BiotechTube
Home/Pulmatrix/David L. Hava
DL

David L. Hava

Chief Scientific Officer

Pulmatrix

Therapeutic Areas

RespiratoryNeurology

Pulmatrix Pipeline

DrugIndicationPhase
PUR3100Acute MigrainePhase 2
PUR1800Acute Exacerbations in COPD / Respiratory DiseasesPhase 1b
PUR1900Allergic Bronchopulmonary Aspergillosis (ABPA) in AsthmaPhase 1b/2a
PUR0200Chronic Obstructive Pulmonary Disease (COPD)Formulation Development

Leadership Team at Pulmatrix

TR
Ted Raad
Chief Executive Officer
JW
John W. Bubb
Chief Financial Officer
MI
Margaret Isman
Chief Operating Officer
WJ
William J. Cook
Senior Vice President, Pharmaceutical Sciences
RW
Robert W. Clarke
Vice President, Discovery & Non-Clinical Development
JB
James B. M. Roach
Former Chief Medical Officer
RC
Robert Clarke
Chairman of the Board
RR
Ronald R. Blanck
Independent Director
AG
Alfred G. Merriweather
Independent Director
PL
Peter Ludlum
Independent Director
View full Pulmatrix profile